OmniBuds hearables are powered by an AI-native programmable operating system, designed to monitor vital signs, including heart and respiration rates, as well as users’ physical activities and audio experiences. The concept is intended to combine high sensing accuracy, on-device data collection, and privacy-preserving processing and was conceived by Nokia Bell Labs in Cambridge, as a research-oriented and human-centered platform.
Now, the project will have the chance to progress from the laboratory and into everyday life. "This engagement between Nokia and Cambridge Future Tech offers an accelerated external research commercialization pathway to harness the innovation developed by Nokia Bell Labs and utilize Cambridge Future Tech’s venture building prowess, to create new products and services for augmenting people’s lives," the venture builder states.
Billions of people around the world are already familiar with putting intelligent devices in or on their ears, and the ear has long been targeted by researchers and companies alike as a window into the body for vital sign monitoring. Cambridge Future Tech intends to quickly scale OmniBuds to meet the growing demand for advanced health monitoring.
The company's engagement with Nokia Bell Labs, the global industrial research arm of Nokia and birthplace of transformative technologies from the transistor to information theory, will ensure that the OmniBuds hearables platform gets a window for commercial success worldwide.
"Partnering with an institution as prestigious as Nokia Bell Labs is a privilege. Their track record for pioneering innovation is unmatched, and we’re excited to collaborate to advance cutting-edge technologies. OmniBuds has the potential to completely transform the health tech space and positively impact people's lives around the world," says Owen Thompson, CEO and co-founder of Cambridge Future Tech.
"This partnership will enable us to push OmniBuds forward, creating a true breakthrough in personal health monitoring. We aim to bring this disruptive technology to market, accelerating its growth and driving significant change in the healthcare industry worldwide."
Mike Chen, Vice President of Ventures and Partnerships at Nokia, commented: "This engagement between Nokia and Cambridge Future Tech offers an accelerated external research commercialization pathway to harness the innovation developed by Nokia Bell Labs and utilize Cambridge Future Tech’s venture building prowess, to create new products and services for augmenting people’s lives."
Cambridge Future Tech has created 80+ highly skilled jobs, raising over $10m in external funding, and over $5m in grant funding for its ventures. Working with leading universities and technology transfer offices, Cambridge Future Tech will co-found eight new companies in 2024 - ahead of the target to co-found a further 40 DeepTech ventures within five years. Cambridge Future Tech will build an additional eight ventures each year with its corporate partners. Recent work has also included industry giants AngloAmerican, Cemex Ventures, and a partnership with CERN, the home of the Large Hadron Collider.
www.camfuturetech.com
www.bell-labs.com
www.omnibuds.tech
